Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP
Articles by Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP

Managing Hematologic Cancer Therapies and Reducing COVID-19 Risk
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Chance G. Partlow, PharmD Candidate,Caitlin M. Sacco, PharmD Candidate In this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.

Improving Outcomes for Patients With Breast Cancer
ByJerry Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlin M. Sacco, PharmD Candidate Current cancer research focuses heavily on adjunct immunotherapy in combination with traditional chemotherapy.

AML Genomic Landscape Plays Key Role in Treatment
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlin M. Sacco Numerous therapeutic options are available for acute myeloid leukemia, but more research is needed to determine how best to use them.

CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas
ByJerry A. Barbee Jr, PharmD, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlyn Tompkins, PharmD Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.

Renal Cell Carcinoma is Treatable and Curable
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Taylor A. VandenBerg Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.

Plethora of Clinical Trials Explore Gastric Cancer Treatments
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Taylor A. VandenBerg, PharmD candidate Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.

CAR-NK Cell Immunotherapy Shows Promise
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Caitlyn Tompkins Patients with relapsed or refractory lymphomas may benefit from CAR-NK cell immunotherapy and Have fewer adverse events.

Vaccines Play a Role in Cancer Treatment
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Sam Sowell, PharmD Candidate There Is Room for Improvement in Treating Malignancies Caused by Infectious Agents, Especially Considering the Cost Differential

What Are the Newest Breast Cancer Treatment Options?
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Matthew Bailey, PharmD Candidate,William Ray Stevens, PharmD Candidate Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results

SBRT Improves Options for Prostate Cancer
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Meagan Balding, PharmD Candidate,D. Garrett Smith, PharmD candidate For some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.

Cancer Pain Treatment Remains a Challenge
ByJerry A. Barbee Jr, PharmD, BCPS, CPh,Glenn Schulman, PharmD, MS, BCPS, BCACP BCGP, BCIDP,Matthew Bailey, PharmD Candidate,Meagan Balding, PharmD Candidate,Amanda Boyer, PharmD Candidate Some patients are hesitant to use this class of drugs because of the stigma of potential addiction.